The Contribution of Host Cells to <i>Pneumocystis</i> Immunity: An Update

<i>Pneumocystis</i> is a ubiquitous atypical fungus that is distributed globally. The genus comprises morphologically similar but genetically heterogeneous species that have co-evolved with specific mammalian hosts as obligate intra-pulmonary pathogens. In humans, <i>Pneumocystis j...

Full description

Bibliographic Details
Main Authors: Patricia Otieno-Odhiambo, Sean Wasserman, J. Claire Hoving
Format: Article
Language:English
Published: MDPI AG 2019-04-01
Series:Pathogens
Subjects:
Online Access:https://www.mdpi.com/2076-0817/8/2/52
id doaj-d809e75cb9164c47820f3b3f7d2f10c9
record_format Article
spelling doaj-d809e75cb9164c47820f3b3f7d2f10c92020-11-24T20:46:16ZengMDPI AGPathogens2076-08172019-04-01825210.3390/pathogens8020052pathogens8020052The Contribution of Host Cells to <i>Pneumocystis</i> Immunity: An UpdatePatricia Otieno-Odhiambo0Sean Wasserman1J. Claire Hoving2AFGrica Medical Mycology Research Unit, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town 7925, South AfricaWellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town 7925, South AfricaAFGrica Medical Mycology Research Unit, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town 7925, South Africa<i>Pneumocystis</i> is a ubiquitous atypical fungus that is distributed globally. The genus comprises morphologically similar but genetically heterogeneous species that have co-evolved with specific mammalian hosts as obligate intra-pulmonary pathogens. In humans, <i>Pneumocystis jirovecii</i> is the causative organism of Pneumocystis pneumonia (PCP) in immunocompromised individuals, a serious illness frequently leading to life-threatening respiratory failure. Initially observed in acquired immunodeficiency syndrome (AIDS) patients, PCP is increasingly observed in immunocompromised non-AIDS patients. The evolving epidemiology and persistently poor outcomes of this common infection will require new strategies for diagnosis and treatment. A deeper understanding of host immune responses and of the cells that mediate them will improve the chance of developing new treatment strategies. This brief review provides an update on recent studies on the role of host immunity against <i>Pneumocystis</i>.https://www.mdpi.com/2076-0817/8/2/52<i>Pneumocystis</i><i>Pneumocystis</i> life formsalveolar macrophagesdendritic cellslymphocytes
collection DOAJ
language English
format Article
sources DOAJ
author Patricia Otieno-Odhiambo
Sean Wasserman
J. Claire Hoving
spellingShingle Patricia Otieno-Odhiambo
Sean Wasserman
J. Claire Hoving
The Contribution of Host Cells to <i>Pneumocystis</i> Immunity: An Update
Pathogens
<i>Pneumocystis</i>
<i>Pneumocystis</i> life forms
alveolar macrophages
dendritic cells
lymphocytes
author_facet Patricia Otieno-Odhiambo
Sean Wasserman
J. Claire Hoving
author_sort Patricia Otieno-Odhiambo
title The Contribution of Host Cells to <i>Pneumocystis</i> Immunity: An Update
title_short The Contribution of Host Cells to <i>Pneumocystis</i> Immunity: An Update
title_full The Contribution of Host Cells to <i>Pneumocystis</i> Immunity: An Update
title_fullStr The Contribution of Host Cells to <i>Pneumocystis</i> Immunity: An Update
title_full_unstemmed The Contribution of Host Cells to <i>Pneumocystis</i> Immunity: An Update
title_sort contribution of host cells to <i>pneumocystis</i> immunity: an update
publisher MDPI AG
series Pathogens
issn 2076-0817
publishDate 2019-04-01
description <i>Pneumocystis</i> is a ubiquitous atypical fungus that is distributed globally. The genus comprises morphologically similar but genetically heterogeneous species that have co-evolved with specific mammalian hosts as obligate intra-pulmonary pathogens. In humans, <i>Pneumocystis jirovecii</i> is the causative organism of Pneumocystis pneumonia (PCP) in immunocompromised individuals, a serious illness frequently leading to life-threatening respiratory failure. Initially observed in acquired immunodeficiency syndrome (AIDS) patients, PCP is increasingly observed in immunocompromised non-AIDS patients. The evolving epidemiology and persistently poor outcomes of this common infection will require new strategies for diagnosis and treatment. A deeper understanding of host immune responses and of the cells that mediate them will improve the chance of developing new treatment strategies. This brief review provides an update on recent studies on the role of host immunity against <i>Pneumocystis</i>.
topic <i>Pneumocystis</i>
<i>Pneumocystis</i> life forms
alveolar macrophages
dendritic cells
lymphocytes
url https://www.mdpi.com/2076-0817/8/2/52
work_keys_str_mv AT patriciaotienoodhiambo thecontributionofhostcellstoipneumocystisiimmunityanupdate
AT seanwasserman thecontributionofhostcellstoipneumocystisiimmunityanupdate
AT jclairehoving thecontributionofhostcellstoipneumocystisiimmunityanupdate
AT patriciaotienoodhiambo contributionofhostcellstoipneumocystisiimmunityanupdate
AT seanwasserman contributionofhostcellstoipneumocystisiimmunityanupdate
AT jclairehoving contributionofhostcellstoipneumocystisiimmunityanupdate
_version_ 1716812993745911808